Literature DB >> 11855824

Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.

Sachiko Yamaguchi1, Kumi Iwata, Masabumi Shibuya.   

Abstract

The flt-1 gene encodes for both the full-length receptor Flt-1 (VEGFR-1) and a soluble form designated sFlt-1. sFlt-1 carries the VEGF-binding domain of Flt-1 as well as a 31-amino-acid stretch derived from an intron and tightly binds VEGF, suppressing its angiogenic activity. The flt-1 gene has so far been identified only in mammals and is highly expressed in placenta as well as in vascular endothelial cells. In placenta, sFlt-1 is abundant in the trophoblast layer during pregnancy, suggesting that it is a negative regulator to excess angiogenesis and vascular permeability at the feto-maternal border in mammals. However, we show here for the first time that the flt-1 gene exists and is highly conserved in chickens. Surprisingly, the chicken flt-1 gene also encodes for sFlt-1 in addition to the full-length receptor. Similar to the mammalian sFlt-1, chicken sFlt-1 carries the VEGF-binding domain and a 31-amino-acid carboxyl region derived from an intron, which was significantly homologous to that in mammals. Chicken sFlt-1 is expressed early in embryogenesis. These findings strongly suggest that the natural antiangiogenic molecule sFlt-1 is widely conserved in vertebrates and regulates the angiogenic process. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855824     DOI: 10.1006/bbrc.2002.6478

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.

Authors:  Gamze Tan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-16       Impact factor: 2.416

2.  VEGF-PLCgamma1 pathway controls cardiac contractility in the embryonic heart.

Authors:  Wolfgang Rottbauer; Steffen Just; Georgia Wessels; Nicole Trano; Patrick Most; Hugo A Katus; Mark C Fishman
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

Review 3.  Sequential drug delivery to modulate macrophage behavior and enhance implant integration.

Authors:  Erin M O'Brien; Gregory E Risser; Kara L Spiller
Journal:  Adv Drug Deliv Rev       Date:  2019-05-16       Impact factor: 15.470

Review 4.  Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.

Authors:  Zhi Huang; Shi-Deng Bao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 5.  Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.

Authors:  Masabumi Shibuya
Journal:  J Biochem       Date:  2012-11-21       Impact factor: 3.387

Review 6.  VEGFR and type-V RTK activation and signaling.

Authors:  Masabumi Shibuya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

7.  Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.

Authors:  Masabumi Shibuya
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

8.  In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.

Authors:  Gabor Szalai; Yi Xu; Roberto Romero; Tinnakorn Chaiworapongsa; Zhonghui Xu; Po Jen Chiang; Hyunyoung Ahn; Birgitta Sundell; Olesya Plazyo; Yang Jiang; Mary Olive; Bing Wang; Suzanne M Jacques; Faisal Qureshi; Adi L Tarca; Offer Erez; Zhong Dong; Zoltan Papp; Sonia S Hassan; Edgar Hernandez-Andrade; Nandor Gabor Than
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

Review 9.  Placental Angiogenesis in Mammals: A Review of the Regulatory Effects of Signaling Pathways and Functional Nutrients.

Authors:  Zihao Huang; Shuangbo Huang; Tongxing Song; Yulong Yin; Chengquan Tan
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

10.  Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.

Authors:  Ewa Robak; Anna Sysa-Jedrzejewska; Tadeusz Robak
Journal:  Mediators Inflamm       Date:  2003-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.